Schedule of Segment Reporting Information by Segment |
Net revenue, cost of sales, gross margin, operating expenses, and operating income (loss) for each period were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In Millions) |
|
Dec 28, 2024 |
|
|
Intel Products |
|
|
|
|
|
|
|
|
|
|
|
|
CCG |
|
DCAI |
|
NEX |
|
Total Intel Products |
|
Intel Foundry |
|
All Other |
|
Corporate Unallocated |
|
Intersegment Eliminations |
|
Total Consolidated |
Revenue |
|
$ |
30,290
|
|
|
$ |
12,817
|
|
|
$ |
5,842
|
|
|
$ |
48,949
|
|
|
$ |
17,543
|
|
|
$ |
3,824
|
|
|
$ |
—
|
|
|
$ |
(17,215) |
|
|
$ |
53,101
|
|
Cost of sales |
|
14,569 |
|
|
6,792 |
|
|
2,457 |
|
|
23,818
|
|
|
25,596 |
|
|
1,831 |
|
|
1,919 |
|
|
(17,408) |
|
|
35,756
|
|
Gross margin (loss) |
|
15,721
|
|
|
6,025
|
|
|
3,385
|
|
|
25,131
|
|
|
(8,053) |
|
|
1,993
|
|
|
(1,919) |
|
|
193
|
|
|
17,345
|
|
Operating expenses |
|
4,801 |
|
|
4,687 |
|
|
2,454 |
|
|
11,942
|
|
|
5,355 |
|
|
2,077 |
|
|
9,299 |
|
|
350 |
|
|
29,023
|
|
Operating income (loss) |
|
$ |
10,920
|
|
|
$ |
1,338
|
|
|
$ |
931
|
|
|
$ |
13,189
|
|
|
$ |
(13,408) |
|
|
$ |
(84) |
|
|
$ |
(11,218) |
|
|
$ |
(157) |
|
|
$ |
(11,678) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In Millions) |
|
Dec 30, 2023 |
|
|
Intel Products |
|
|
|
|
|
|
|
|
|
|
|
|
CCG |
|
DCAI |
|
NEX |
|
Total Intel Products |
|
Intel Foundry |
|
All Other |
|
Corporate Unallocated |
|
Intersegment Eliminations |
|
Total Consolidated |
Revenue |
|
$ |
29,258
|
|
|
$ |
12,635
|
|
|
$ |
5,774
|
|
|
$ |
47,667
|
|
|
$ |
18,910
|
|
|
$ |
5,608
|
|
|
$ |
—
|
|
|
$ |
(17,957) |
|
|
$ |
54,228
|
|
Cost of sales |
|
14,606 |
|
|
6,420 |
|
|
3,095 |
|
|
24,121
|
|
|
21,471 |
|
|
2,475 |
|
|
2,136 |
|
|
(17,686) |
|
|
32,517
|
|
Gross margin (loss) |
|
14,652
|
|
|
6,215
|
|
|
2,679
|
|
|
23,546
|
|
|
(2,561) |
|
|
3,133
|
|
|
(2,136) |
|
|
(271) |
|
|
21,711
|
|
Operating expenses |
|
5,139 |
|
|
4,595 |
|
|
2,475 |
|
|
12,209
|
|
|
4,394 |
|
|
2,054 |
|
|
3,029 |
|
|
(68) |
|
|
21,618
|
|
Operating income (loss) |
|
$ |
9,513
|
|
|
$ |
1,620
|
|
|
$ |
204
|
|
|
$ |
11,337
|
|
|
$ |
(6,955) |
|
|
$ |
1,079
|
|
|
$ |
(5,165) |
|
|
$ |
(203) |
|
|
$ |
93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In Millions) |
|
Dec 31, 2022 |
|
|
Intel Products |
|
|
|
|
|
|
|
|
|
|
|
|
CCG |
|
DCAI |
|
NEX |
|
Total Intel Products |
|
Intel Foundry |
|
All Other |
|
Corporate Unallocated |
|
Intersegment Eliminations |
|
Total Consolidated |
Revenue |
|
$ |
31,773
|
|
|
$ |
16,856
|
|
|
$ |
8,409
|
|
|
$ |
57,038
|
|
|
$ |
27,491
|
|
|
$ |
5,530
|
|
|
$ |
—
|
|
|
$ |
(27,005) |
|
|
$ |
63,054
|
|
Cost of sales |
|
16,826 |
|
|
7,081 |
|
|
3,856 |
|
|
27,763
|
|
|
28,052 |
|
|
2,425 |
|
|
2,875 |
|
|
(24,927) |
|
|
36,188
|
|
Gross margin (loss) |
|
14,947
|
|
|
9,775
|
|
|
4,553
|
|
|
29,275
|
|
|
(561) |
|
|
3,105
|
|
|
(2,875) |
|
|
(2,078) |
|
|
26,866
|
|
Operating expenses |
|
6,740 |
|
|
5,577 |
|
|
3,021 |
|
|
15,338
|
|
|
4,608 |
|
|
1,931 |
|
|
2,758 |
|
|
(103) |
|
|
24,532
|
|
Operating income (loss) |
|
$ |
8,207
|
|
|
$ |
4,198
|
|
|
$ |
1,532
|
|
|
$ |
13,937
|
|
|
$ |
(5,169) |
|
|
$ |
1,174
|
|
|
$ |
(5,633) |
|
|
$ |
(1,975) |
|
|
$ |
2,334
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In Millions) |
|
Dec 28, 2024 |
|
|
Cost of Sales |
|
Operating Expenses |
|
Total |
Acquisition-related costs |
|
$ |
879 |
|
|
$ |
165 |
|
|
$ |
1,044 |
|
Share-based compensation |
|
875 |
|
|
2,535 |
|
|
3,410 |
|
Restructuring and other charges1
|
|
— |
|
|
6,970 |
|
|
6,970 |
|
Other |
|
165 |
|
|
(371) |
|
|
(206) |
|
Total corporate unallocated expenses |
|
$ |
1,919
|
|
|
$ |
9,299
|
|
|
$ |
11,218
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In Millions) |
|
Dec 30, 2023 |
|
|
Cost of Sales |
|
Operating Expenses |
|
Total |
Acquisition-related costs |
|
$ |
1,235 |
|
|
$ |
172 |
|
|
$ |
1,407 |
|
Share-based compensation |
|
705 |
|
|
2,524 |
|
|
3,229 |
|
Restructuring and other charges1
|
|
— |
|
|
(62) |
|
|
(62) |
|
Other |
|
196 |
|
|
395 |
|
|
591 |
|
Total corporate unallocated expenses |
|
$ |
2,136
|
|
|
$ |
3,029
|
|
|
$ |
5,165
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In Millions) |
|
Dec 31, 2022 |
|
|
Cost of Sales |
|
Operating Expenses |
|
Total |
Acquisition-related costs |
|
$ |
1,341 |
|
|
$ |
185 |
|
|
$ |
1,526 |
|
Share-based compensation |
|
663 |
|
|
2,465 |
|
|
3,128 |
|
Patent settlement |
|
204 |
|
|
— |
|
|
204 |
|
Optane inventory impairment |
|
723 |
|
|
— |
|
|
723 |
|
Restructuring and other charges1
|
|
— |
|
|
2 |
|
|
2 |
|
Other |
|
(56) |
|
|
106 |
|
|
50 |
|
Total corporate unallocated expenses |
|
$ |
2,875
|
|
|
$ |
2,758
|
|
|
$ |
5,633
|
|
1 See "Note 7: Restructuring and Other Charges" within Notes to Consolidated Financial Statements for further information.
|